NCT00687180已完成4 期
Mycophenolate vs Azathioprin in Autoimmune Hepatitis
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10 receiving mycophenolat mofetil.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •De novo autoimmune hepatitis
排除标准
- •age below 18
- •pregnancy
研究组 & 干预措施
I
Active Comparator
MMF
干预措施: Treatment with mycophenolat mofetil (Drug)
II
Active Comparator
干预措施: Treatment with azathioprin (Drug)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
4 期
Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line TherapyAutoimmune HepatitisNCT05221411Leiden University Medical Center86
尚未招募
2 期
Induction of Remission in Autoimmune Hepatitis With Azathioprine vs. MMFAutoimmune HepatitisNCT06650124Institute of Liver and Biliary Sciences, India108
招募中
3 期
Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first line therapy: a Randomized trialAutoimmune hepatitis1001965410003816NL-OMON49891eids Universitair Medisch Centrum86
Unknown
4 期
Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard TherapyHepatitis, AutoimmuneImmunosuppressionPrimary Biliary CholangitisNCT04376528West China Hospital89
已完成
2 期
Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus NephritisLupus NephritisNCT02949349Genovate Biotechnology Co., Ltd.,32